- Home
- BKU vs AGIO Comparison
BKU vs AGIO Comparison
Compare BKU & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKU
- AGIO
- Stock Information
- Founded
- BKU 2009
- AGIO 2007
- Country
- BKU United States
- AGIO United States
- Employees
- BKU N/A
- AGIO N/A
- Industry
- BKU Savings Institutions
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- BKU Finance
- AGIO Health Care
- Exchange
- BKU Nasdaq
- AGIO Nasdaq
- Market Cap
- BKU 2.7B
- AGIO 2.6B
- IPO Year
- BKU 2011
- AGIO 2013
- Fundamental
- Price
- BKU $40.72
- AGIO $53.78
- Analyst Decision
- BKU Hold
- AGIO Buy
- Analyst Count
- BKU 10
- AGIO 7
- Target Price
- BKU $36.20
- AGIO $52.33
- AVG Volume (30 Days)
- BKU 923.6K
- AGIO 726.1K
- Earning Date
- BKU 10-22-2024
- AGIO 10-31-2024
- Dividend Yield
- BKU 2.85%
- AGIO N/A
- EPS Growth
- BKU N/A
- AGIO N/A
- EPS
- BKU 2.44
- AGIO 11.80
- Revenue
- BKU $919,935,000.00
- AGIO $32,871,000.00
- Revenue This Year
- BKU N/A
- AGIO $33.38
- Revenue Next Year
- BKU $6.83
- AGIO $163.06
- P/E Ratio
- BKU $16.66
- AGIO $4.56
- Revenue Growth
- BKU 3.57
- AGIO 36.79
- 52 Week Low
- BKU $24.34
- AGIO $20.96
- 52 Week High
- BKU $41.65
- AGIO $62.58
- Technical
- Relative Strength Index (RSI)
- BKU 64.62
- AGIO 59.21
- Support Level
- BKU $39.99
- AGIO $43.25
- Resistance Level
- BKU $41.65
- AGIO $62.58
- Average True Range (ATR)
- BKU 1.14
- AGIO 2.73
- MACD
- BKU 0.49
- AGIO 0.71
- Stochastic Oscillator
- BKU 87.52
- AGIO 54.47
About BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located primarily throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.